Close

NGSX Financial Facts

Total operating expenses: 4.17M
Selling, general and administrative: 2.78M
See Full Income Statement

Additional paid-in capital: 243.43M
Accumulated other comprehensive gain (loss): 1K
See Full Balance Sheet

NeurogesX (NGSX) Earnings

  |   Expand Research on NGSX
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -0.9% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -5.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/8/12 Q411 -$0.34-$0.41 +$0.07$2.96M$3.01M N/A Details
10/31/11 Q311 -$0.43-$0.44 +$0.01$2.89M$3.14M N/A Details
8/9/11 Q211 -$0.81-$0.72 -$0.09$2.5M$3.04M N/A Details
4/29/11 Q111 -$0.75-$0.68 -$0.07$3.2M$3.01M N/A Details
11/3/10 Q310 -$0.72-$0.65 -$0.07N/AN/A N/A Details